Wall Street Zen Upgrades Kewaunee Scientific (NASDAQ:KEQU) to Buy

Kewaunee Scientific (NASDAQ:KEQU) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock opened at $58.94 on Friday. The firm has a fifty day moving average price of $39.60 and a two-hundred day moving average price of $47.70. The company has a market cap of $167.39 million, a PE ratio of 15.39 and a beta of 0.70. Kewaunee Scientific has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The company has a debt-to-equity ratio of 0.92, a current ratio of 2.20 and a quick ratio of 1.54.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, June 25th. The technology company reported $1.95 EPS for the quarter. The company had revenue of $77.15 million during the quarter. Kewaunee Scientific had a net margin of 4.74% and a return on equity of 26.02%.

Insider Transactions at Kewaunee Scientific

In other news, CFO Donald T. Gardner III sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $37.75, for a total transaction of $113,250.00. Following the completion of the transaction, the chief financial officer directly owned 15,358 shares of the company’s stock, valued at approximately $579,764.50. This trade represents a 16.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas David Hull III sold 1,844 shares of the firm’s stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $32.44, for a total transaction of $59,819.36. Following the transaction, the chief executive officer directly owned 36,072 shares of the company’s stock, valued at $1,170,175.68. The trade was a 4.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 14.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently made changes to their positions in KEQU. Truffle Hound Capital LLC bought a new position in shares of Kewaunee Scientific during the 4th quarter worth about $619,000. American Century Companies Inc. lifted its holdings in Kewaunee Scientific by 18.0% during the 4th quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock valued at $2,122,000 after purchasing an additional 5,221 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in Kewaunee Scientific by 3.3% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after purchasing an additional 891 shares during the last quarter. Wedbush Securities Inc. bought a new position in Kewaunee Scientific during the 4th quarter valued at about $262,000. Finally, Invesco Ltd. bought a new position in Kewaunee Scientific during the 4th quarter valued at about $6,545,000. 32.69% of the stock is owned by institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.